Who we are
We improve human health by applying the science of machine learning to develop algorithms to detect disease and monitor progression.
What we do
Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on liver disease detection and monitoring.
Did You Know...
1.Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcome. Hepatology 64(1): 73-84
2.Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 107: 811–826
Our Unique Liver Diagnostics Tests
The non-invasive solution for liver health evaluations
The Fibronostics Team
Meet The Team Behind LiverFASt™
Our Blogs
The Progression of Liver Disease
Anything that keeps your liver from doing its job may put your life in danger.
There are many different types of liver disease. But no matter what type you have, the damage to your liver is likely to progress in a similar
Liver Disease May Raise Risk of Heart Problems: Study
MONDAY, June 24 (HealthDay News) -- A new study adds to growing evidence of a link between a common liver diseaseassociated with obesity and high risk for heart disease.
Is cirrhosis associated with increased risk of stroke?
Summary: Cirrhosis was associated with increased risk of stroke, especially hemorrhagic, in a study that included a representative sample of more than 1.6 million Medicare beneficiaries, according to an article.